BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3018936)

  • 1. Clinical experience with charcoal and resin hemoperfusion.
    Hughes R; Williams R
    Semin Liver Dis; 1986 May; 6(2):164-73. PubMed ID: 3018936
    [No Abstract]   [Full Text] [Related]  

  • 2. Earlier charcoal haemoperfusion in fulminant hepatic failure.
    Gimson AE; Braude S; Mellon PJ; Canalese J; Williams R
    Lancet; 1982 Sep; 2(8300):681-3. PubMed ID: 6126626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of prostacyclin, PGI2, in the prevention of platelet aggregation during charcoal haemoperfusion.
    Langley PG; Hughes RD; Ton HY; Silk DB; Williams R
    Int J Artif Organs; 1979 Jul; 2(4):207-10. PubMed ID: 378864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute liver failure.
    Silk DB; Williams R
    Br J Hosp Med; 1979 Nov; 22(5):437, 440-1, 445-6. PubMed ID: 540198
    [No Abstract]   [Full Text] [Related]  

  • 5. Sorbent removal of adriamycin in vitro and in vivo.
    Winchester JF; Rahman A; Tilstone WJ; Kessler A; Mortensen L; Schreiner GE; Schein PS
    Cancer Treat Rep; 1979; 63(11-12):1787-93. PubMed ID: 526913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated charcoal and resin haemoadsorbents: in vitro drug removal and blood compatibility studies.
    Gottschall S; Falkenhagen D; Schmitt E; Courtney JM; Klinkmann H
    Biomed Biochim Acta; 1984; 43(2):245-8. PubMed ID: 6732761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charcoal hemoperfusion for liver failure.
    Weston MJ
    Lancet; 1982 Oct; 2(8305):983. PubMed ID: 6127478
    [No Abstract]   [Full Text] [Related]  

  • 8. Removal of inhibitors of brain Na+, K+-ATPase by hemoperfusion in fulminant hepatic failure.
    Seda HW; Hughes RD; Gove CD; Williams R
    Artif Organs; 1984 May; 8(2):174-8. PubMed ID: 6329147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemoperfusion across charcoal in acute hepatic failure in the dog].
    Horák J; Horký J; Rábl M
    Cesk Gastroenterol Vyz; 1980 Mar; 34(2):86-95. PubMed ID: 7388982
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with the use of charcoal haemoperfusion: is prostacyclin required?
    Kennedy HJ; Greaves M; Triger DR
    Life Support Syst; 1985; 3(2):115-22. PubMed ID: 3894813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin eliminates the bioincompatibility of charcoal haemoperfusion.
    Weston MJ; Woods HF; Bunting S; Moncada S; Vane JR
    Proc Eur Dial Transplant Assoc; 1979; 16():225-31. PubMed ID: 398492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct hemoperfusion with noncoated charcoal of high adsorption capacity derived from thermosetting resin.
    Otsubo O; Horiuchi T; Uchima T; Takai N; Tsunetsugu T; Inou T
    Trans Am Soc Artif Intern Organs; 1980; 26():124-8. PubMed ID: 7245468
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
    Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
    Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
    [No Abstract]   [Full Text] [Related]  

  • 14. Acid citrate dextrose reduces platelet retention during in vitro and in vivo dog hemoperfusion: a comparative study of different charcoal adsorbers.
    Tangerman A; Snel P; van Schaik A; van Tongeren JH
    Artif Organs; 1981 Nov; 5(4):357-62. PubMed ID: 7325877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic study of polyetherurethane coated bead-type activated charcoal for direct hemoperfusion.
    Kawanishi H; Nishiki M; Sugiyama M; Cho T; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1983 Mar; 32(1):9-14. PubMed ID: 6863016
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem.
    Blei AT
    Hepatology; 1991 Feb; 13(2):376-9. PubMed ID: 1847353
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current concepts of hemoperfusion through activated charcoal in the treatment of internal diseases].
    Dmitriev AA
    Ter Arkh; 1983; 55(6):140-8. PubMed ID: 6351328
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical results of charcoal hemoperfusion: studies of 55 cases extending over 250 incidents].
    Agishi T; Yamashita N; Ota K
    Nihon Rinsho; 1980 Dec; 38(12):4697-702. PubMed ID: 7253246
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances of adsorbents for hemoperfusion in China.
    Yu YT; Chen CZ
    Biomater Artif Cells Artif Organs; 1990; 18(4):499-505. PubMed ID: 2285812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of artificial liver support.
    Williams R; Ede R; Hughes R
    Int J Clin Pharmacol Res; 1985; 5(6):381-7. PubMed ID: 3005180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.